CO5261512A1 - Metodo y composiciones para el tratamiento de las enfermedades pulmonares - Google Patents

Metodo y composiciones para el tratamiento de las enfermedades pulmonares

Info

Publication number
CO5261512A1
CO5261512A1 CO00083427A CO00083427A CO5261512A1 CO 5261512 A1 CO5261512 A1 CO 5261512A1 CO 00083427 A CO00083427 A CO 00083427A CO 00083427 A CO00083427 A CO 00083427A CO 5261512 A1 CO5261512 A1 CO 5261512A1
Authority
CO
Colombia
Prior art keywords
compositions
treatment
pulmonary diseases
separately
time
Prior art date
Application number
CO00083427A
Other languages
English (en)
Spanish (es)
Inventor
Peter N Goodfellow
Richard Nieman
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5261512A1 publication Critical patent/CO5261512A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO00083427A 1999-11-02 2000-11-02 Metodo y composiciones para el tratamiento de las enfermedades pulmonares CO5261512A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
CO5261512A1 true CO5261512A1 (es) 2003-03-31

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00083427A CO5261512A1 (es) 1999-11-02 2000-11-02 Metodo y composiciones para el tratamiento de las enfermedades pulmonares

Country Status (29)

Country Link
EP (1) EP1225866A4 (no)
JP (1) JP2003513028A (no)
KR (1) KR20020057988A (no)
CN (1) CN1387404A (no)
AP (1) AP2002002496A0 (no)
AR (1) AR029189A1 (no)
AU (1) AU1357501A (no)
BG (1) BG106748A (no)
BR (1) BR0015270A (no)
CA (1) CA2388333A1 (no)
CO (1) CO5261512A1 (no)
CZ (1) CZ20021512A3 (no)
DZ (1) DZ3225A1 (no)
EA (1) EA200200518A1 (no)
EC (1) ECSP003747A (no)
HK (1) HK1049107A1 (no)
HU (1) HUP0203152A3 (no)
IL (1) IL149367A0 (no)
MA (1) MA26841A1 (no)
MX (1) MXPA02004350A (no)
NO (1) NO20022057L (no)
OA (1) OA12076A (no)
PE (1) PE20011005A1 (no)
PL (1) PL355261A1 (no)
SK (1) SK7592002A3 (no)
TR (1) TR200201211T2 (no)
TW (1) TWI242431B (no)
WO (1) WO2001032127A2 (no)
ZA (1) ZA200203435B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2459757C (en) * 2001-09-19 2011-08-30 Altana Pharma Ag Combination
MXPA04003668A (es) * 2001-10-31 2004-07-22 Merck Patent Gmbh Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
WO2004087149A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co. Ltd. 医薬組成物
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7174794A (en) * 1993-06-18 1995-01-17 Smithkline Beecham Corporation Compounds
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
EP1225866A4 (en) 2004-04-21
CN1387404A (zh) 2002-12-25
AR029189A1 (es) 2003-06-18
WO2001032127A3 (en) 2001-12-06
TWI242431B (en) 2005-11-01
PL355261A1 (en) 2004-04-05
OA12076A (en) 2006-05-04
JP2003513028A (ja) 2003-04-08
IL149367A0 (en) 2002-11-10
HK1049107A1 (zh) 2003-05-02
PE20011005A1 (es) 2001-09-28
NO20022057D0 (no) 2002-04-30
ECSP003747A (es) 2002-05-23
AU1357501A (en) 2001-05-14
CZ20021512A3 (cs) 2003-04-16
SK7592002A3 (en) 2002-11-06
CA2388333A1 (en) 2001-05-10
KR20020057988A (ko) 2002-07-12
WO2001032127A2 (en) 2001-05-10
NO20022057L (no) 2002-06-27
EA200200518A1 (ru) 2002-10-31
MXPA02004350A (es) 2002-11-07
HUP0203152A3 (en) 2004-06-28
BG106748A (en) 2003-02-28
MA26841A1 (fr) 2004-12-20
HUP0203152A2 (hu) 2003-01-28
TR200201211T2 (tr) 2002-08-21
DZ3225A1 (fr) 2001-05-10
BR0015270A (pt) 2002-06-18
EP1225866A2 (en) 2002-07-31
ZA200203435B (en) 2003-06-25
AP2002002496A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
AR039947A1 (es) Formulacion farmaceutica que comprende nicotina
IL172705A0 (en) Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases
ES2250416T3 (es) Estimulante de secreciohn de hormona de crecimiento.
CO4970819A1 (es) Tratamiento de disfuncion sexual femenina en una hembra humana
NO20061325L (no) Kombinasjon av legemidler for behandling av neoplasmer
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
ATE333885T1 (de) Verwendung von sulodexid zur behandlung von reizdarm
NO20050718L (no) Topikal behandling av hudsykdommer
DK0563023T3 (da) Anvendelse af vævsfaktor pathway inhibitor til fremstilling af et medikament til anvendelse ved en fremgangsmåde til hæmnin
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
CO5261512A1 (es) Metodo y composiciones para el tratamiento de las enfermedades pulmonares
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
DE69932939D1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
NO20061184L (no) Fremgangsmater og blandinger for behandling av herpes-infeksjoner
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
ES2124983T3 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
DE602004024221D1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
BR0311613A (pt) Métodos para inibição, tratamento ou prevenção de sintomas de atrofia da pele, ou atrofia epitelial ou da mucosa nas mulheres e utilização de composto
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
NO971453D0 (no) Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer
WO2000015207A3 (en) Combination for the treatment of inflammation using elastine inhibitor(s) and antibacterial agent(s)

Legal Events

Date Code Title Description
FC Application refused